How to Choose a GLP-1 Telehealth Provider: A Buyer's Checklist

The GLP-1 telehealth market is crowded, and almost every program is designed to be judged on one number: the sticker price on its landing page. That is the wrong number. A provider is a year-long relationship, and the real question is what the whole relationship costs and what you get for it. Here is the five-point checklist we run every provider through before it earns a spot on the Cost-Efficiency Index.

The five-minute version

Before you enter a credit card, get an honest answer on five things: (1) can you see the full price and model a year of it, (2) does the provider actually serve your state, (3) which molecules and formulations it offers, (4) who is clinically responsible for your prescription, and (5) how easily you can cancel. A program that is transparent on all five is usually a good program. One that is cagey on any of them is telling you something.

1. Price transparency: can you model a full year?

The most reliable signal of a fair program is a price you can see before you sign up — and that does not change on you at month two. Watch for teaser rates: a low intro price that quietly steps up after the first month, which is the single biggest gap between a provider's advertised cost and what you actually pay. If you cannot build a clean 12-month total from the pricing page, treat that as a cost, not a convenience. We break the mechanics down in the true monthly cost of GLP-1, and price transparency is a weighted factor in our methodology for exactly this reason.

2. States served: no coverage gamble

Telehealth prescribing is regulated state by state, so "available" does not always mean available to you. Some of the cheapest sticker prices on the market come from operators serving only a handful of states — great value if you live in one, a dead end if you do not. Providers that publish all-50-state access, such as Ondra Health and CoreAge Rx, take that variable off the table. Confirm your state is served before you get attached to a price.

3. Molecule and formulation options

Two molecules dominate weight-management prescribing: semaglutide and tirzepatide. In pivotal trials, semaglutide 2.4 mg produced roughly 15% mean weight loss over 68 weeks¹, and tirzepatide produced up to about 21% over 72 weeks². A good provider discloses the price of both so you can choose on evidence and cost, not just on what it happens to stock. Also check the formulation: injectable versus oral or sublingual, and whether the provider offers FDA-approved brand-name products or compounded medication only. We compare the two molecules head-to-head in semaglutide vs tirzepatide.

4. Clinical oversight: who is behind the prescription?

Compounded GLP-1 medications are not FDA-approved products, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs³ — so the pharmacy and clinicians behind your prescription do a lot of the work FDA approval would otherwise do. Look for a licensed clinician who reviews your history, a real dose-titration plan rather than a one-size dose, and a pharmacy you can name. LegitScript certification is a useful, verifiable signal that a pharmacy meets recognized standards. We weigh whether compounded medication is genuinely safe to buy in is compounded semaglutide legit and safe.

5. Cancellation and contract flexibility

The last check is the exit. Can you cancel in one step, or is there a bundled coaching subscription you cannot unbundle, an auto-renewing multi-month commitment, or a cancellation fee? Contract flexibility is part of the true cost: a program you can leave cleanly protects you if the medication is not right for you, and it keeps your total commitment predictable.

Putting it together

Run all five checks and the field narrows fast. Rank the finalists on value, not sticker price, using our provider reviews and the side-by-side compare tool, and sanity-check the numbers with the cost calculators. The best provider for you is the one that is honest about all five — and that you can afford for a full year, not just the first month.